General Information of the Compound
Compound ID
CP0570841
Compound Name
(1-methylpiperidin-4-yl)-(3-phenyl-3,4-dihydropyrazol-2-yl)methanone
    Show/Hide
Structure
Formula
C16H21N3O
Molecular Weight
271.364
Canonical SMILES
CN1CCC(CC1)C(=O)N1N=CCC1c1ccccc1
    Show/Hide
InChI
InChI=1S/C16H21N3O/c1-18-11-8-14(9-12-18)16(20)19-15(7-10-17-19)13-5-3-2-4-6-13/h2-6,10,14-15H,7-9,11-12H2,1H3
    Show/Hide
InChIKey
OKWCYSLFQVMVIB-UHFFFAOYSA-N
Physicochemical Property
logP
2.2876
Rotatable Bonds
2
Heavy Atom Count
20
Polar Areas
35.91
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
3
Complexity
20

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 155393270
ChEMBL ID
CHEMBL4527680
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00954, Receptor-interacting serine/threonine-protein kinase 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000100 U-937 Homo sapiens (Human)  1
1
IC50 = 7940 nM
   TI
   LI
   LO
   TS